China’s pharmaceutical industry will be at the global forefront in the next 5 years, Fosun Pharma chairman says

With a solid foundation and growing research investments, China’s pharma companies are narrowing the gap with the industry’s global powers, Shanghai Fosun Pharmaceutical chairman Wu Yifang says.

Read the original article at South China Morning Post